home > articles > asd (autism spectrum disorder) > neuroglial activation and neuroinflammation in the brain of patients with autism

Glutathione Articles - ASD (Autism Spectrum Disorders)

Neuroglial Activation and Neuroinflammation in the Brain of Patients with Autism
Diana L. Vargas, MD, Caterina Nascimbene, MD, Chitra Krishnan, MHS, Andrew W. Zimmerman, MD, and Carlos A. Pardo, MD
American Neurological Association 2005; 57.
> download the full text version as a PDF

Autism is a neurodevelopmental disorder characterized by impaired communication and social interaction and may be accompanied by mental retardation and epilepsy. Its cause remains unknown, despite evidence that genetic, environmental, and immunological factors may play a role in its pathogenesis. To investigate whether immune-mediated mechanisms are involved in the pathogenesis of autism, we used immunocytochemistry, cytokine protein arrays, and enzymelinked immunosorbent assays to study brain tissues and cerebrospinal fluid (CSF) from autistic patients and determined the magnitude of neuroglial and inflammatory reactions and their cytokine expression profiles. Brain tissues from cerebellum, midfrontal, and cingulate gyrus obtained at autopsy from 11 patients with autism were used for morphological studies. Fresh-frozen tissues available from seven patients and CSF from six living autistic patients were used for cytokine protein profiling. We demonstrate an active neuroinflammatory process in the cerebral cortex, white matter, and notably in cerebellum of autistic patients. Immunocytochemical studies showed marked activation of microglia and astroglia, and cytokine profiling indicated that macrophage chemoattractant protein (MCP)–1 and tumor growth factor–_1, derived from neuroglia, were the most prevalent cytokines in brain tissues. CSF showed a unique proinflammatory profile of cytokines, including a marked increase in MCP-1. Our findings indicate that innate neuroimmune reactions play a pathogenic role in an undefined proportion of autistic patients, suggesting that future therapies might involve modifying neuroglial responses in the brain. Ann Neurol 2005;57:000–000.

> download the full text version as a PDF

Glutathione Experts | What is Glutathione (GSH)? | Glutathione Articles | GSH FAQs | GSH & Diseases | Contact

These statements have not been evaluated by the Food and Drug Administration. This product is not meant to diagnose, treat, cure, or prevent any disease.
©Copyright 2007 The Glutathione Experts, Wellness Pharmacy ®. All rights reserved.  Site Sponsored by Wellness Pharmacy® >>